Camfil, the leader in clean air solutions, announced a series of webinars aimed at educating customers on the importance of Indoor Air Quality (IAQ). The first webinar, set for the 21st of February at 3:00 pm CET, will be titled Measuring and Reducing Airbourne Pathogens in Hospital Environments.
Infection control critically effects functions within hospital environments. Guidelines are set in order to decontaminate surfaces, hands, tools and additional areas of hospitals. But what guidelines are set in order to protect the air within hospitals? In this webinar, Camfil will discuss:
- 1.How PM1, PM2.5 and PM10 particles effect the human body
- 2.IAQ regulations within hospitals
- 3.Internal and external air quality contamination sources
- 4.IAQ best practices
“Working closely with hospitals around the world has given Camfil great insights into the range of air quality problems that arise within hospital environments,” David Cruise, CEBI Marketing Manager at Camfil, said. “This webinar is designed to help share best practices within the industry.”
The webinar will be hosted by Anders Hedström, IAQ Global Manager at Camfil. With 35 years of experience within IAQ, Hedström performs in many international lectures and conducts research for the Swedish government on topics around IAQ and its effects on the human body.
To sign up for the webinar, visit https://goo.gl/zcaHvu
Camfil is a global leader in the air filtration industry with more than half a century of experience in developing and manufacturing sustainable clean air solutions that protect people, processes and the environment against harmful airborne particles, gases and emissions. These solutions are used globally to benefit human health, increase performance and reduce energy consumption in a wide range of air filtration applications. Our 28 manufacturing plants, three R&D sites, local sales offices and over 4,000 employees provide service and support to our customers around the world. Camfil is headquartered in Stockholm, Sweden. Group sales total more than SEK 7.2 billion per year.